These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Alemtuzumab in solid organ transplantation and in composite tissue allotransplantation. Weissenbacher A; Boesmueller C; Brandacher G; Oellinger R; Pratschke J; Schneeberger S Immunotherapy; 2010 Nov; 2(6):783-90. PubMed ID: 21091110 [TBL] [Abstract][Full Text] [Related]
8. Current status of composite tissue allotransplantation. Siemionow M; Bozkurt M; Kulahci Y Handchir Mikrochir Plast Chir; 2007 Jun; 39(3):145-55. PubMed ID: 17602375 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppression without immunosuppression? How to be a tolerant individual in a dangerous world. Kirk AD Transpl Infect Dis; 1999 Mar; 1(1):65-75. PubMed ID: 11428972 [TBL] [Abstract][Full Text] [Related]
11. Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration. Kueckelhaus M; Fischer S; Seyda M; Bueno EM; Aycart MA; Alhefzi M; ElKhal A; Pomahac B; Tullius SG Transpl Int; 2016 Jun; 29(6):655-62. PubMed ID: 26265179 [TBL] [Abstract][Full Text] [Related]
12. Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model. Xu H; Elster E; Batty D; Berning J; Burkly L; Kampen R; Swanson S; Tadaki D; Harlan D; Kirk A Transplant Proc; 2001; 33(1-2):223-4. PubMed ID: 11266788 [No Abstract] [Full Text] [Related]
13. Use of anti-CD40 ligand monoclonal antibody as antirejection therapy in a murine peripheral nerve allograft model. Jensen JN; Tung TH; Mackinnon SE; Brenner MJ; Hunter DA Microsurgery; 2004; 24(4):309-15. PubMed ID: 15274190 [TBL] [Abstract][Full Text] [Related]